Related by context. All words. (Click for frequent words.) 62 meta regression 62 retrospective cohort 59 multicentre prospective 59 NHAMCS 58 CHADS2 58 randomized controlled trials RCTs 58 interobserver 58 prospective longitudinal 58 metaanalysis 57 observational cohort study 57 posttest 57 prospective nonrandomized 57 HORIZONS AMI trial 57 clinicopathologic 57 postintervention 57 Meta analyzes 56 histopathologic 56 perfusion CT 56 eCRF 56 retrospective observational study 56 PROTECT II 56 retrospective cohort study 55 logistic regression analyzes 55 genomewide 55 binary logistic regression 55 CT perfusion 55 COR Analyzer 55 semistructured interviews 55 NAMCS 55 Echocardiographic 55 prospective observational studies 55 QEEG 55 multiple logistic regression 55 RE LY ® 55 transrectal ultrasound 54 transvaginal sonography 54 EEG recordings 54 CHAMPION PCI 54 retrospectively reviewed 54 prospective multicentre 54 TAXUS ARRIVE 54 ROCKET AF 54 longitudinal cohort 54 electrophysiologic 54 F FDG PET 54 AVERROES 54 electrocardiographic ECG 54 FFR measurements 54 chest radiographs 54 multivariate regression analysis 54 prognostic variables 54 COR Analyzer System 54 prospective observational cohort 54 FDG PET CT 54 multivariate logistic regression 54 ophthalmoscopy 53 meta analytic 53 CIMZIA TM certolizumab pegol 53 Phase IIIB IV 53 nonrandomized 53 Histologic 53 multivariable analyzes 53 multivariable analysis 53 retrospectively analyzed 53 inter rater reliability 53 semistructured 53 Qscan 53 urodynamic 53 #F FDG PET 53 echocardiographic 53 polysomnographic 53 PARTNER Trial 53 chemoprevention trials 53 RE LY 53 FDG PET scans 53 DLQI 53 Phase IIb III 53 Multiple logistic regression 53 MMSE score 53 hepatic lesions 53 TNM staging 53 eculizumab therapy 53 prognostic indicators 53 electrocardiographic 53 ultrasonographic 53 CARE HF 53 conditional logistic regression 53 ad hoc querying 53 angiographic outcomes 53 NSABP B 53 Interrater reliability 53 GPRD 53 multiple linear regression 53 PCI ExTRACT TIMI 52 multivariable logistic regression 52 Multivariate logistic regression 52 prospectively defined 52 neuropsychological assessment 52 convergent validity 52 myocardial viability 52 DCE MRI 52 randomized Phase 2b 52 multivariate analyzes 52 neuropsychological assessments 52 scintigraphic 52 FACIT 52 PIB PET 52 DSM IV diagnoses 52 phase IIIb 52 SYNTAX trial 52 linear regressions 52 genotypic resistance 52 biostatistical 52 transcranial Doppler ultrasound 52 CT angiograms 52 stepwise logistic regression 52 NIHSS score 52 journal Ophthalmology 52 total hip arthroplasties 52 nondiagnostic 52 postdischarge 52 BR.# 52 randomized blinded 52 CaPSURE 52 ECG waveforms 52 BARI 2D 52 APPRAISE 52 computed tomographic CT 52 cerebral oximetry 52 postoperative complication 52 interrater reliability 52 prospective multicenter 52 prespecified secondary 52 antithrombotic therapies 52 cytologic 52 randomized controlled multicenter 52 Coronary CTA 52 RE LY trial 52 histopathological 52 acetabular fractures 52 Primary endpoints 52 genomic biomarker 52 ventilation perfusion 52 multivariate Cox 52 confirmed CCyR 52 IMPROVE HF 52 MS DRG 52 inferential statistics 51 KN excels 51 T2 lesions 51 cystoscopic 51 EQ 5D 51 neuro radiologists 51 radionuclide imaging 51 oncologic outcomes 51 preadmission 51 exploratory endpoints 51 summative assessments 51 PROactive study 51 CORE OM 51 multicenter randomized placebo controlled 51 multicenter randomized controlled 51 journal CHEST 51 univariate 51 neuroimaging studies 51 FDG-PET/CT 51 SYNTAX 51 dimensional echocardiography 51 pCLE 51 rEEG 51 Lewy bodies DLB 51 poststroke 51 softcopy 51 Post hoc 51 Y BOCS 51 Likert scale 51 variance ANOVA 51 audiometer 51 comorbid diagnoses 51 digital subtraction angiography 51 worklists 51 Acute Decompensated Heart Failure 51 SF #v# 51 ECG gated 51 logistic regressions 51 OPT CHF 51 carotid artery narrowing 51 Visual acuity 51 logistic regression model 51 IMPACT DCM 51 venous thromboembolic disease 51 Solorel 51 VADT 51 diffusion tensor 51 methodologically sound 51 Brief Psychiatric 51 immunohistochemical 51 multimodality 51 multicenter prospective 51 tumor histology 51 OLYMPIA registry 51 Electrophysiological 51 CAMMS# 51 PSQI 50 blinded randomized placebo controlled 50 interobserver reliability 50 radiographic outcomes 50 preoperative diagnosis 50 spirometric 50 QIDS SR 50 subscore 50 semiquantitative 50 resectable pancreatic cancer 50 postmarketing adverse 50 FENO 50 clevidipine 50 Cronbach alpha 50 histologic examination 50 electrophysiological 50 posttreatment 50 Quantitative EEG 50 SLNB 50 cardiac perfusion 50 NIH CPSI 50 helical CT 50 computed tomographic scans 50 NEVO RES 50 EnRhythm MRI SureScan pacing 50 SPECT CT imaging 50 intraobserver 50 percutaneous biopsy 50 fundus photography 50 nonrandomized studies 50 UPDRS scores 50 PREVENT IV 50 Regression analyzes 50 Multivariable logistic regression 50 ExTRACT TIMI 50 electroencephalograms 50 pretest probability 50 plain radiographs 50 endoscopic remission 50 MGCD# clinical trials 50 Carotid Revascularization Endarterectomy vs. 50 HEDIS R 50 management biostatistical analysis 50 worklist 50 psychiatric comorbidities 50 STEP BD 50 PIRLS 50 patient subpopulations 50 chest radiography 50 limiting generalizability 50 pharmacokinetic PK 50 drug eluting stent implantation 50 ER CHOP 50 neurotherapeutics 50 relapsed MM 50 thorough QT 50 oral anticoagulation 50 indicates cardio circulatory 50 coronary CT angiography 50 CareEngine 50 Injury Severity Score 50 cervical cytology 50 MelaFind pivotal 50 Viatronix V3D Colon 50 Cardiotoxicity 50 blind placebo 50 intratympanic 50 predictive validity 50 Complications Trial 50 Computed tomographic 50 HealthGrades analyzed 50 sociodemographic factors 50 Quantitative PCR 50 Randomized controlled 50 echocardiographic parameters 50 warfarin dosage 50 trials RCTs 50 transient elastography 50 affective psychosis 50 rEEG ® 50 debulking surgery 50 prospectively enrolled 50 CT urography 50 SIMPADICO 50 ENGAGE AF TIMI 50 transesophageal echocardiography TEE 50 Randomized Evaluation 50 recurrent malignant glioma 50 carotid revascularization 50 SEER registries 50 PHQ 9 50 Liver biopsies 50 Diffusion weighted 50 Phase 1a clinical 50 SPIVA 50 guideline concordant 49 subanalysis 49 transcriptional profiling 49 SLN biopsy 49 ANCOVA 49 nasal symptom 49 gauge vitrectomy 49 perinatal outcomes 49 Screening Trial DMIST 49 angiographically 49 KCCQ 49 AVOREN 49 summative 49 Arch Intern Med 49 multicentre 49 cCTA 49 neurophysiologic 49 SYNTAX Score 49 bronchoscopic 49 coronary CTA 49 upper endoscopy 49 colonoscopic 49 syndromic 49 differentiate squamous 49 Univariate 49 ENDEAVOR clinical 49 Poisson regression 49 TKAs 49 Clinical Antipsychotic Trials 49 point Likert scale 49 clinico pathological 49 Histopathologic 49 Symptom Checklist 49 DMIST 49 viral kinetic 49 SPIRIT FIRST 49 journal Resuscitation 49 BRFSS 49 preoperative intraoperative 49 JACC Cardiovascular Interventions 49 PERMP 49 Hemodynamic 49 coronary revascularization 49 analyzable 49 CTEPH 49 Phase 2b randomized 49 multicenter multinational 49 pharmacodynamic PD 49 placebo controlled dose escalation 49 Clinicaltrials.gov 49 CIBIC Plus 49 bepotastine besilate nasal spray 49 transcranial Doppler 49 transcriptomic 49 Postoperative complications 49 Kaplan Meier analysis 49 NMIBC 49 Renal Cell Carcinoma RCC 49 nodal metastases 49 comorbid depression 49 Pharmacodynamic 49 Urogenital Distress Inventory 49 Visual Analogue Scale VAS 49 GAMMAGARD 49 angiography CCTA 49 EmbraceAC 49 Neuropsychiatric Inventory 49 EMPHASIS HF trial 49 GI endoscopy 49 interrater 49 RRMS patients 49 estimated GFR 49 EVEREST II 49 Kruskal Wallis test 49 retest reliability 49 METHODS 49 desvenlafaxine succinate 49 Mantel Haenszel 49 Intervention Effectiveness CATIE 49 underwent resection 49 psychodynamic therapy 49 core needle biopsies 49 longitudinal cohort study 49 laser Doppler 49 sociodemographic characteristics 49 histologically confirmed 49 randomized multicenter trial 49 galiximab 49 electromyographic EMG 49 pharmacokinetic pharmacodynamic 49 syncopal episodes 49 sonographic examinations 49 EURIDIS 49 subgroup analyzes 49 randomizing patients 49 electron beam computed tomography 49 Comorbidity 49 electroencephalographic 49 periprocedural MI 49 logistic regression models 49 ACS NSQIP 49 clinicopathological 49 Radiographic 49 xCELLigence System 49 radiographic imaging 49 transthoracic echocardiography 49 randomisation 49 Oncotype DX Recurrence Score 49 intravenous tPA 49 prodromal symptoms 49 Operative mortality 49 correlational 49 Edge STudy 49 antimicrobial susceptibility 49 Kaplan Meier estimate 49 MERIT ES 49 generalized estimating 49 Bonferroni correction 49 Secondary efficacy endpoints 49 multivariate statistical 49 renal biopsy 49 hemodynamic parameters 49 etiologic 49 clinical pharmacology studies 49 RefSeq 49 Coronary Artery Bypass Graft 49 ConclusionThis 49 molecular biomarker 49 INTERMACS 49 pressure monitoring ABPM 49 actigraphy 49 Phase III VISTA 49 empirically validated 49 IMS MIDAS 49 pigmented skin lesions 49 BioMAP 49 transrectal ultrasound guided 49 coronary computed tomography 49 Functional neuroimaging 49 neuropsychological evaluations 49 cardiac magnetic resonance 48 prospective multicenter study 48 neurocognitive functioning 48 hepatic arterial 48 Coronary artery calcium 48 sputum specimens 48 obstetric ultrasound 48 transabdominal 48 PRIMO CABG 48 double blinded randomized 48 MADIT CRT trial 48 cerebral angiography 48 fetal echocardiography 48 demyelinating 48 Multivariate analysis revealed 48 TAXUS ATLAS clinical 48 proton MR spectroscopy 48 haematological 48 sonographic 48 urodynamic studies 48 TAXUS V 48 phase IIb study 48 undetectable HBV DNA 48 psychiatric comorbidity 48 parenteral antibiotics 48 Skin sterol 48 dimensional computed tomography 48 miRNA profiling 48 coronary artery stenosis 48 HPA Consultants 48 NNT = 48 polysomnography PSG 48 TURBT 48 TAXUS VI 48 RECORD1 48 prelicensure 48 electrodiagnostic 48 thyroid carcinoma 48 MERLIN TIMI 48 FDG PET scan 48 ABSORB trial 48 MSCT 48 TRITON TIMI 48 NLSY 48 functional neuroimaging 48 Sociodemographic 48 postoperative radiographs 48 covariance ANCOVA 48 PreGen Plus 48 skin sterol 48 antiarrhythmic drug 48 NSQIP 48 covariate 48 randomized multicenter 48 adjuvant tamoxifen 48 intraoperative ultrasound 48 liver biopsies 48 premorbid 48 pharmacogenetic testing 48 computerized tomography scan 48 adnexal masses 48 hemodynamic measurements 48 preintervention 48 nomograms 48 pretransplant 48 Vertos II 48 CFQ R 48 Outcomes Study 48 biochemical recurrence 48 geologic interpretations 48 GPNMB expression 48 neurocognitive outcomes 48 antiretroviral naïve 48 Nationwide Inpatient Sample 48 multivariable Cox 48 HCAHPS survey 48 timepoints 48 toxicogenomic 48 Multicenter AIDS 48 ECASS 48 journal Rheumatology 48 stratifying patients 48 mammographic 48 Phase III AFFIRM 48 Quality Indicators 48 prospective observational 48 Asthma Intervention 48 PLCO 48 telerehabilitation 48 hyperacute 48 prospective randomized controlled 48 V3D Colon 48 CLIRS 48 postoperative mortality 48 subthreshold depression 48 Zevalin consolidation 48 STRIDE PD 48 depressive symptomatology 48 lung nodule 48 preoperative evaluation 48 Ocular Surface Disease 48 resting ECG 48 inhospital mortality 48 Medicsight ColonCAD 48 quantitative gene expression 48 univariate analyzes 48 HRQL 48 MDCT angiography 48 recurrent glioblastoma multiforme 48 Preoperatively 48 Electroencephalography 48 TMS Therapy 48 comorbid psychiatric disorders 48 nonfatal MI 48 pd ratings 48 PreCISe study 48 Marketrack 48 axillary lymph node 48 pharmacokinetics PK 48 placebo controlled multicenter 48 RNA seq 48 antipsychotic prescribing 48 MBHO 48 colonography 48 quantitative EEG 48 Wisconsin Sleep Cohort 48 disease progression TTP 48 radiation dosimetry 48 MDCT scans 48 cytoreductive nephrectomy 48 bivariate analyzes 48 undergoing coronary angiography 48 Targretin capsules 48 elevated bilirubin 48 HOMA IR 48 MEND CABG 48 Reporting System AERS 48 boards IRBs 48 preclinical efficacy 48 computed tomography scan 48 meta analysis pooling 48 blinded randomized controlled 48 ThinPrep Pap Test 48 LV dysfunction 48 OptiVol 48 Charlson Comorbidity Index 48 ShearWave Elastography 48 duplex ultrasonography 47 haematologic 47 endoscopist 47 prospective cohort 47 QRISK 47 TNSS 47 Digital Mammographic Imaging 47 serum cotinine 47 placebo controlled Phase III 47 atherosclerotic renal artery stenosis 47 PROLARIS 47 MEND CABG II 47 ZACTIMA 47 electrocardiograms ECGs 47 glaucomatous 47 Negative Symptoms 47 imaging FMRI 47 cerebral autoregulation 47 genotype phenotype 47 TQT studies 47 AVADO 47 Nissen meta analysis 47 MTWA testing 47 virological response 47 p# biomarker 47 Symptom severity 47 oncological outcomes 47 audiometric 47 microsimulation model 47 ancrod 47 clinicopathological features 47 interobserver agreement 47 radiofrequency RF ablation 47 Glasgow Coma Scale 47 Crohn Disease Activity 47 sNDA submission 47 ASSERT trial 47 metabolite concentrations 47 renal artery stenosis 47 Cochrane Systematic Review 47 arteriography 47 Bayesian inference 47 QTc 47 Fractional Flow Reserve 47 Val HeFT 47 transesophageal echocardiography 47 PCPT 47 extracolonic findings 47 CPAP adherence 47 radiofrequency catheter ablation 47 slit lamp 47 sacral neuromodulation 47 percutaneous vertebroplasty 47 postmarketing surveillance 47 Data Extraction 47 parasitological 47 Phase III randomized controlled 47 serum lipid levels 47 arthroplasties 47 definite stent thrombosis 47 ADCS CGIC 47 color Doppler sonography 47 MoxDuo TM IR 47 Integrated Postsecondary Education 47 postapproval 47 NHANES surveys 47 PiB PET 47 psychometrically sound 47 LightLab OCT 47 familial aggregation 47 Angiographic 47 element ICP AES 47 Pearson correlation coefficient 47 Current Beneficiary 47 CLARITY study 47 spiral computed tomography 47 schizophreniform disorder 47 neurocognitive function 47 hematologic parameters 47 serologic testing 47 Kaplan Meier estimates 47 preoperative MRI 47 gadolinium enhanced 47 electrocardiography ECG 47 axial length 47 cardioembolic stroke 47 underwent coronary angiography 47 IMV ServiceTrak 47 BI RADS ® 47 multicentre randomized 47 MADIT II 47 TrendTrader system 47 unblinded 47 underwent surgical resection 47 dyssynchrony 47 pathologic examination 47 Phase #/#a 47 graft patency 47 MGd 47 pharmacoeconomic analysis 47 morphologic 47 iniparib BSI 47 sinonasal 47 psychotherapeutic treatments 47 OBPM 47 EuroSCORE 47 methotrexate therapy 47 attain statistical significance 47 sonographic examination 47 unblind 47 optical coherence tomography OCT 47 FDG PET imaging 47 PET CT scans 47 CYP#D# inhibitor 47 abdominal ultrasound 47 psychoeducation 47 NYHA functional class 47 FDG PET 47 perimetry 47 prospectively randomized 47 sonographic findings 47 sociodemographic variables 47 sensitivity specificity 47 hematologists oncologists 47 intracerebral haemorrhage 47 echo planar 47 histopathologic findings 47 symptomatic paroxysmal AF 47 postoperative chemotherapy 47 HORIZONS AMI 47 Logistic regression 47 ROC curves 47 symptom checklist 47 HYVET 47 semistructured interview 47 overnight polysomnography 47 EGS# 47 Kaplan Meier curve 47 National Inpatient Sample 47 multicenter trials 47 pre operatively 47 secondary efficacy endpoint 47 morphometric vertebral fractures 47 CCyR 47 KRAS gene mutations 47 EDEMA3 trial 47 arthrography 47 www.sanbolic.com 47 morphometry 47 chest radiograph 47 USRDS 47 PACS workstations 47 sirolimus eluting stents 47 biostatistical analysis 47 HRQOL 47 cardiac repolarization 47 NSDUH 47 KLAS CPOE Digest 47 ACCORD ADVANCE 47 graphing capabilities 47 histopathology 47 nonpsychotic 47 Scale EDSS 47 Cardiology PACS 47 Multiple linear regression 47 SEDASYS ® System 47 ICSs 47 polysomnogram 47 budesonide MMX Phase III 47 State Examination MMSE 47 NHANES III 47 histologic subtype 47 diagnostic angiography 47 biometry 47 diagnostic modality 47 placebo controlled clinical 47 journal Epilepsia 47 carotid endarterectomy CEA 47 neurocognitive impairment 47 CINQUIL 47 oral diclofenac 47 NSTE ACS 47 sociodemographic 47 pretreatment serum 47 radical cystectomy 47 Kids Inpatient Database 47 intravenous methylnaltrexone 47 Neuropsychiatric Inventory NPI 47 somatosensory evoked potentials 47 Amelior ED R 47 carotid artery stenting CAS 47 patientswith 47 including eniluracil ADH 47 MSLT 47 Decompensated Heart Failure 47 WorkTrends 47 SUVmax 47 HPV genotyping 47 BCIRG 47 Visensia 47 null responder 46 clinical 46 bone scintigraphy 46 Subgroup analyzes 46 Current Controlled Trials 46 HCUP 46 TRA 2P 46 label dose titration 46 ambulatory settings 46 bolus dose 46 Pearson correlation coefficients 46 eC SSRS 46 methodologic 46 EBRI Issue Brief 46 Postoperative 46 Abdominal ultrasound 46 postoperative radiotherapy 46 Thrombolysis 46 CUSTOM III 46 histopathological examination 46 Kaplan Meier survival 46 intracardiac 46 audiogram 46 methodological limitations 46 intraclass correlation coefficients 46 Detailed explanations 46 HRCT 46 PD2i CA 46 NIHSS 46 histological subtypes 46 QTinno ™ 46 multimodality imaging 46 MDQ 46 ICD Registry 46 histologically proven 46 Tumor Response 46 EBRI ICI 46 pivotal bioequivalence 46 ductal adenocarcinoma 46 psychophysiological 46 NATRECOR ® 46 PITX2 methylation 46 Http :/ www.reversephonewar.com 46 teleconsultation 46 QALE 46 hemodynamic variables 46 opacification 46 histologic findings 46 immunohistochemical analysis 46 BMC Psychiatry 46 differential diagnoses 46 postoperative AF 46 Visual Analog 46 ultrasonographic examination 46 BoNTA 46 Subgroup analysis 46 LATITUDE Patient Management 46 monoinfected patients 46 TargetScan 46 bibliometric 46 digital rectal examination 46 APACHE II 46 AHFS 46 endoscopic examinations 46 multivariable regression 46 serum HCV RNA 46 MHQP 46 pharmaco 46 pharmacodynamic parameters 46 Histopathological 46 adjuvant systemic 46 Logistic regression analyzes 46 logistic regression analysis 46 PD2i R 46 MedDRA 46 PFO migraine 46 pathophysiological mechanisms 46 pelvic ultrasound 46 QTc prolongation 46 euthymic patients 46 summative evaluation 46 autonomic dysfunction 46 malignant neoplasm 46 subscores 46 EDEMA3 46 IPEDS 46 Phase IIIb study 46 randomized Phase IIb 46 percutaneous drainage 46 Treatment Diabetic Retinopathy 46 DQI 46 Perfusion CT 46 CLIRS trial 46 prospective multicenter randomized 46 phylogenetic analyzes 46 histological subtype 46 ADONIS 46 sequential dose escalation 46 bivariate 46 perfusion MRI 46 IVIVC 46 psychometric properties 46 BETAS 46 demonstrated clinically meaningful 46 viral kinetics 46 dimensional sonography 46 bronchoscopic procedure 46 prospective randomized multicenter 46 Logistic regression analysis 46 Secondary endpoints 46 tomography scan 46 posterolateral fusion 46 hemodynamically significant 46 pharmacodynamic markers 46 moderately emetogenic 46 multicenter randomized clinical 46 coronary angiograms 46 SciVal Spotlight 46 Socio demographic 46 drillhole database 46 Promotional Audit 46 dosimetric 46 syndromal 46 adjuvant cisplatin 46 chi squared 46 immunostaining 46 Afib 46 aneurysmal subarachnoid hemorrhage 46 YMRS 46 psychopharmacological 46 prostate cancer CaP 46 Nesiritide 46 Linear regression 46 IQR 46 PRECiSE 46 Keynote Transaction Perspective 46 induced sputum 46 posttransplant 46 presurgical 46 APEX AMI trial 46 tipranavir ritonavir 46 confirmatory clinical 46 USpella 46 GEM OS1 46 Appropriateness Criteria 46 petrographic studies 46 endoscopic ultrasound EUS 46 BODE index 46 genomewide association studies 46 multivariate regression 46 underwent CABG 46 hepatorenal syndrome 46 NCDB 46 VAD implantation 46 Secondary endpoints included 46 endometrial thickening 46 dietary questionnaires 46 total knee arthroplasties 46 prospectively stratified 46 psychiatric morbidity 46 SEER registry 46 hematopoietic cancers 46 Kaplan Meier curves 46 patient acuity 46 ICD therapy 46 perfusion defects 46 upper endoscopies 46 telemonitoring imaging 46 computed tomographic 46 CALGB 46 DecisionBase 46 gene expression microarray 46 Polysomnography 46 REMINYL ® 46 depressive symptom 46 CUSTOM II 46 cerebral oxygenation 46 diagnosing ADHD 46 EBUS 46 CA9 SCAN 46 Pharmacokinetic parameters 46 ACUITY trial 46 tolerability pharmacokinetics 46 NICE SUGAR 46 ICD implantation 46 PreDx DRS 46 Phase 2b kidney transplant 46 cytomegalovirus infection 46 epidemiologic studies 46 Montgomery Åsberg Depression 46 rALLy trial 46 HRQoL 46 VATS lobectomy 46 NuroPro PD 46 Stretta System 46 fasting lipid 46 LungCAD 46 pathologic diagnosis 46 SGAs 46 underwent percutaneous coronary 46 randomized controlled clinical 46 wavelet transform 46 Electrocardiogram ECG 46 formal pharmacokinetic PK 46 Fibromyalgia Impact Questionnaire 46 discharge summaries 46 PSA kinetics 46 abnormal cytology 46 prognostic significance 46 covariates 46 Functional MRI 46 Phase Ib study 46 adenoidectomy 46 OTG Healthcare